Antidepressant discontinuation syndrome: A state-of-the-art clinical review

E Vieta - European Neuropsychopharmacology, 2023 - Elsevier
Antidepressant drugs are prescribed to patients with depressive, anxiety disorders, and
other conditions. Evidence about antidepressant discontinuation syndrome (ADS) and …
被引用次数：13 相关文章

Antidepressant discontinuation syndrome: A state-of-the-art clinical review

M Fornaro, C Cattaneo, D De Berardis… - EUROPEAN …, 2023 - ricerca.unich.it
Antidepressant drugs are prescribed to patients with depressive, anxiety disorders, and
other conditions. Evidence about antidepressant discontinuation syndrome (ADS) and …

Antidepressant discontinuation syndrome: A state-of-the-art clinical review

M Fornaro, CI Cattaneo… - … : the journal of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Antidepressant drugs are prescribed to patients with depressive, anxiety disorders, and
other conditions. Evidence about antidepressant discontinuation syndrome (ADS) and …

Antidepressant discontinuation syndrome: A state-of-the-art clinical review

M Fornaro, CI Cattaneo, D De Berardis… - … , 2023, vol. 66, p. 1-10, 2023 - diposit.ub.edu
Antidepressant drugs are prescribed to patients with depressive, anxiety disorders, and
other conditions. Evidence about antidepressant discontinuation syndrome (ADS) and …

Antidepressant discontinuation syndrome: A state-of-the-art clinical review.

M Fornaro, CI Cattaneo, D De Berardis… - … : the Journal of the …, 2022 - europepmc.org
Antidepressant drugs are prescribed to patients with depressive, anxiety disorders, and
other conditions. Evidence about antidepressant discontinuation syndrome (ADS) and …